drugset / Trial / NCT02097004
Study of Therapeutic Vaccination With Intensified Schedule Plus Pegasys Dual Therapy on Chronic Hepatitis B Infection
RandomizedParallel-groupOpen-labelTreatment
Summary
A randomized, Open label, Single center, Prospective study to compare efficacy and safety of Therapeutic Vaccination with Intensified schedule plus Pegylated Interferon dual Therapy on Seroclearance of Hepatitis B virus Surface Antigen in Patients with Complete Virological Response Induced by Entecavir
Timeline
- Start
- 2014-04
- Primary completion
- 2018-01
- Completion
- 2018-03-13
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Euvax B Inj | Vaccine | 20 ug | Intramuscular |
| Subject | Peginterferon alfa-2a | Protein / enzyme biologic | 180 ug | Subcutaneous |
| Background | Entecavir | Small molecule | 0.5 mg | — |